Skip to main content
Heather McArthur, MD, Oncology, Dallas, TX

Heather Lynn McArthur MD , MPH

Breast Cancer


Clinical Director of Breast Cancer, Komen Distinguished Chair in Clinical Breast Cancer Research, UT Southwestern

Join to View Full Profile
  • 2201 Inwood Road 3rd floor Nc3500Dallas, TX 75390

  • Phone+1 214-645-4673

Dr. McArthur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Heather McArthur is an oncologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. She received her medical degree from University of Toronto Faculty of Medicine, a fellowship degree from the British Columbia Cancer Agency, a Master of Public Health degree from Harvard University and has been in practice 16 years. She specializes in breast cancer and is experienced in breast cancer, oncology, and internal medicine. She has more than 90 publications and over 500 citings.

Education & Training

  • Memorial-Sloan Kettering Cancer Center
    Memorial-Sloan Kettering Cancer CenterAdvanced Clinical Research Fellowship, Breast Oncology, 2006 - 2010
  • Harvard University
    Harvard UniversityMPH, Clinical Effectiveness, 2006 - 2008
  • British Columbia Cancer Agency/University of British Columbia
    British Columbia Cancer Agency/University of British ColumbiaMedical Oncology Fellowship, 2004 - 2006
  • University of Calgary
    University of CalgaryInternal Medicine Residency, 2001 - 2004
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2001

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2022 - 2026
  • CA State Medical License
    CA State Medical License 2016 - 2022
  • NY State Medical License
    NY State Medical License 2009 - 2019
  • Oncology
    AOA Board of Internal Medicine Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
    Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast CancerFebruary 7th, 2025
  • Pre-Op Immunotherapy Helps Beat Breast Cancer
    Pre-Op Immunotherapy Helps Beat Breast CancerFebruary 7th, 2025
  • Preoperative Immunotherapy Could Enhance Breast Cancer Cure Rates
    Preoperative Immunotherapy Could Enhance Breast Cancer Cure RatesFebruary 4th, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: